bioAffinity Technologies, Inc. - Common Stock (BIAF)
5.2900
+1.8800 (55.13%)
NASDAQ · Last Trade: Sep 27th, 7:37 PM EDT
Detailed Quote
Previous Close
3.410
Open
6.180
Bid
4.850
Ask
4.860
Day's Range
4.650 - 7.290
52 Week Range
0.1340 - 7.290
Volume
99,912,668
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
16,056,579
Chart
About bioAffinity Technologies, Inc. - Common Stock (BIAF)
bioAffinity Technologies, Inc. is a biotechnology company focused on developing innovative diagnostic and therapeutic solutions for the early detection and treatment of cancer. The company leverages its proprietary technologies to create advanced cellular and molecular products aimed at improving patient outcomes, particularly in areas where traditional methods fall short. By harnessing the power of biological mechanisms, bioAffinity seeks to provide healthcare professionals with novel tools for identifying cancer at its earliest stages and tailoring personalized treatment plans for patients. Read More
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with its stock experiencing a dramatic surge. The significant uptick, which saw shares climb by over 52% in premarket trading and reach highs of 79% and 60.71% during Friday's session,
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The S&P 500 also rose, gaining, 0.62% to 6,645.73.
Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products
A new class of Maga Stocks is heating up, blending health, wellness, tech, and critical minerals into some of the most compelling stories on Wall Street today. Here’s why investors are watching:
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0.58% to 46,213.26 while the NASDAQ rose 0.31% to 22,455.17. The S&P 500 also rose, gaining, 0.47% to 6,636.07.
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released three additional case studies – one in which use of CyPath® Lung led to detecting lung cancer at Stage 1A, its earliest and possibly curative stage, and two where risky invasive procedures were avoided for patients facing difficult healthcare choices.
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it will effect a 1-for-30 reverse split of its common stock. Commencing with the opening of trading on the Nasdaq Capital Market on September 19, 2025, the Company’s common stock will trade on a post-split basis under the symbol BIAF. The reverse stock split was approved by the Company’s stockholders at the Company’s annual meeting held on July 25, 2025.
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
